hydrochlorothiazide has been researched along with guanfacine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bouchard, S; Brookman, S; Farooki, MS; Farsky, K; Lalonde, Y | 1 |
| Román, O; Salazar, R; Valenzuela, MA | 1 |
| Heidland, A; Roeckel, A | 1 |
| Distler, A; Kirch, W; Lüth, B | 1 |
1 review(s) available for hydrochlorothiazide and guanfacine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for hydrochlorothiazide and guanfacine
| Article | Year |
|---|---|
Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Female; Guanfacine; Guanidines; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Methyldopa; Middle Aged; Phenylacetates; Random Allocation; Time Factors | 1985 |
[Guanfacine in primary arterial hypertension: a long-term open clinical study].
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Furosemide; Guanfacine; Guanidines; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Phenylacetates; Propranolol | 1982 |
Antihypertensive effect of guanfacine: a double-blind cross-over trial compared with clonidine.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Blood Pressure; Body Weight; Clinical Trials as Topic; Clonidine; Double-Blind Method; Drug Therapy, Combination; Epinephrine; Female; Guanfacine; Guanidines; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Phenoxybenzamine; Phenylacetates; Triamterene | 1980 |
3 other study(ies) available for hydrochlorothiazide and guanfacine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Acute and chronic renal effects of guanfacine in essential and renal hypertension.
Topics: Antihypertensive Agents; Blood Pressure; Creatinine; Drug Therapy, Combination; Electrolytes; Glomerular Filtration Rate; Guanfacine; Guanidines; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Hypertension, Renal; Kidney; Metabolic Clearance Rate; Phenylacetates; Time Factors | 1980 |